Literature DB >> 7744099

Cardiac involvement in collagen diseases.

S T Toumanidis1, C M Papamichael, L G Antoniades, M I Pantelia, N S Saridakis, M E Mavrikakis, D A Sideris, S D Moulopoulos.   

Abstract

The purpose of this study is to evaluate the early morphological and functional abnormalities of the heart in patients with collagen disease. The study population was free of risk factors for coronary artery disease and without any clinically evident cardiac manifestations. In 62 patients with collagen disease (25 with progressive systemic sclerosis, 19 with systemic lupus erythematosus, 15 with rheumatoid arthritis, three with dermatomyositis) and in 40 healthy subjects an echocardiographic study was performed. Echocardiographic examination from the apical four-chamber view was performed at rest and during the end of a 3 min isometric exercise with handgrip. Global and regional ejection fraction of the left ventricle were calculated. In the group with progressive systemic sclerosis the left ventricular mass index was significantly higher than in the control group (110.78 +/- 48.61 vs 82.18 +/- 28.46 g.m-2) and the ejection fraction (53.61 +/- 7.95%) was the lowest of all groups (control: 61.47 +/- 8.52%, systemic lupus erythematosus: 59.04 +/- 8.58%, rheumatoid arthritis: 62.38 +/- 6.88%). Regional ejection fraction analysis revealed a major dysfunction of the proximal segment of the interventricular septum, in all groups. During isometric exercise, the global and regional ejection fraction did not change significantly, although differences between groups disappeared. In rheumatoid arthritis, mitral and aortic valve leaflet separation appeared to be reduced. In the group with systemic lupus erythematosus, mild abnormalities were noticed, although the mean age and duration of the disease were the smallest compared with the other groups. In conclusion, patients with progressive systemic sclerosis mainly present left ventricular hypertrophy with a reduced ejection fraction while rheumatoid arthritis patients show a predominant valve dysfunction.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7744099     DOI: 10.1093/oxfordjournals.eurheartj.a060893

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  6 in total

1.  Aortic valve insufficiency in patients with chronic rheumatic diseases.

Authors:  Paavo Uusimaa; Maija-Liisa Krogerus; Juhani Airaksinen; Markku Linnaluoto; Osmo Tervonen; Markku Hakala
Journal:  Clin Rheumatol       Date:  2005-10-11       Impact factor: 2.980

Review 2.  [Echocardiographic functional analysis of patients with rheumatoid arthritis and collagen diseases].

Authors:  A Hagendorff; D Pfeiffer
Journal:  Z Rheumatol       Date:  2005-05       Impact factor: 1.372

3.  Mitral valve surgery in a patient with rheumatoid arthritis being treated with methotrexate.

Authors:  Yoshiyuki Takami; Hiroshi Ina
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-05

4.  Echocardiographic findings, 24-hour electrocardiographic Holter monitoring in patients with rheumatoid arthritis according to Steinbrocker's criteria, functional index, value of Waaler-Rose titre and duration of disease.

Authors:  M Wisłowska; S Sypuła; I Kowalik
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

Review 5.  Heart involvement in systemic lupus erythematosus: a systemic review and meta-analysis.

Authors:  Junzhe Chen; Ying Tang; Mingsheng Zhu; Anping Xu
Journal:  Clin Rheumatol       Date:  2016-08-09       Impact factor: 2.980

6.  The early cardiovascular changes in pediatric patients with systemic lupus erythematosus.

Authors:  Betul Sozeri; Murat Deveci; Nida Dincel; Sevgi Mir
Journal:  Pediatr Nephrol       Date:  2012-11-08       Impact factor: 3.714

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.